Klaus Wethmar

10PUBLICATIONS
54CO-AUTHORS
Haematological tumoursPsychological methodology, design and analysisHaematologyCellular immunologyCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Mar 13, 2026
IDH2 clonal hematopoiesis and IKAROS loss cooperate in a B-ALL subtype after lenalidomide therapy for multiple myeloma.

Johanna M Horns, Thomas Beder, Axel Künstner

|Dec 06, 2025
Reduced intensity conditioning with 8 Gy total body irradiation in adult patients with acute lymphoblastic leukemia.

Klaus Wethmar, Matthias Edinger, Kerstin Schäfer-Eckart

|Jan 15, 2025
Common hereditary variants of the APOE gene and posttransplant outcome in acute myeloid leukemia.

Julian Ronnacker, Michael Grau, Maximilian Klasmeier

|Feb 26, 2024
Prevalence and clinical impact of CD56 and T-cell marker expression in acute myeloid leukaemia: A single-centre retrospective analysis.

Inna Shaforostova, Simon Call, Georg Evers

|Oct 26, 2023
Inotuzumab Ozogamicin as Induction Therapy for Patients Older Than 55 Years With Philadelphia Chromosome-Negative B-Precursor ALL.

Matthias Stelljes, Simon Raffel, Nael Alakel

|Aug 12, 2023
Complete Metabolic Response to Combined Immune Checkpoint Inhibition after Progression of Metastatic Colorectal Cancer on Pembrolizumab: A Case Report.

Carolin Krekeler, Klaus Wethmar, Jan-Henrik Mikesch

Pageof 2

Frequent Collaborators

3 joint publications

Lara Jürgens

3 joint publications

Wolfgang E Berdel

2 joint publications

Felix Manske

2 joint publications

Wojciech Makalowski